Next Article in Journal
Making Sense of Antisense Oligonucleotide Therapeutics Targeting Bcl-2
Next Article in Special Issue
Development of Peptide Biopharmaceuticals in Russia
Previous Article in Journal
Chitosan/poly(lactic-co-glycolic)acid Nanoparticle Formulations with Finely-Tuned Size Distributions for Enhanced Mucoadhesion
Previous Article in Special Issue
Reprogramming Extracellular Vesicles for Protein Therapeutics Delivery
 
 
Article

Article Versions Notes

Pharmaceutics 2022, 14(1), 96; https://doi.org/10.3390/pharmaceutics14010096
Action Date Notes Link
article pdf uploaded. 1 January 2022 10:08 CET Version of Record https://www.mdpi.com/1999-4923/14/1/96/pdf-vor
article supplementary file uploaded. 1 January 2022 10:08 CET - https://www.mdpi.com/1999-4923/14/1/96#supplementary
article pdf uploaded. 1 January 2022 10:08 CET Updated version of record https://www.mdpi.com/1999-4923/14/1/96/pdf-vor
article xml file uploaded 4 January 2022 04:08 CET Original file -
article xml uploaded. 4 January 2022 04:08 CET Update https://www.mdpi.com/1999-4923/14/1/96/xml
article pdf uploaded. 4 January 2022 04:08 CET Updated version of record https://www.mdpi.com/1999-4923/14/1/96/pdf
article html file updated 4 January 2022 04:09 CET Original file -
article html file updated 4 January 2022 04:10 CET Update -
article html file updated 31 July 2022 01:40 CEST Update https://www.mdpi.com/1999-4923/14/1/96/html
Back to TopTop